David Taber to Longitudinal Studies
This is a "connection" page, showing publications David Taber has written about Longitudinal Studies.
Connection Strength
2.526
-
Etiologies and Outcomes Associated With Tacrolimus Levels Out of a Typical Range That Lead to High Variability in Kidney Transplant Recipients. Ther Drug Monit. 2021 06 01; 43(3):401-407.
Score: 0.145
-
Virtual Crossmatching in Kidney Transplantation: The Wait Is Over. J Am Coll Surg. 2020 04; 230(4):373-379.
Score: 0.133
-
The Impact of Dual Health Care System Use for Obtaining Prescription Medications on Nonadherence in Veterans With Type 2 Diabetes. Ann Pharmacother. 2019 07; 53(7):675-682.
Score: 0.124
-
Change in Mycophenolate and Tacrolimus Exposure by Transplant Vintage and Race. Exp Clin Transplant. 2019 12; 17(6):707-713.
Score: 0.123
-
The impact of time-varying clinical surrogates on disparities in African-American kidney transplant recipients - a retrospective longitudinal cohort study. Transpl Int. 2019 01; 32(1):84-94.
Score: 0.120
-
Characterization of Potentially Unsafe Ambulatory Antibiotic Use and Associated Outcomes in an Adult Kidney Transplant Population. Ann Pharmacother. 2018 10; 52(10):974-982.
Score: 0.118
-
Tacrolimus Trough Concentration Variability and Disparities in African American Kidney Transplantation. Transplantation. 2017 12; 101(12):2931-2938.
Score: 0.114
-
Incidence and impact of adverse drug events contributing to hospital readmissions in kidney transplant recipients. Surgery. 2018 02; 163(2):430-435.
Score: 0.114
-
Improvement in immunosuppression therapy monitoring in organ transplant recipients. Am J Health Syst Pharm. 2017 Sep 01; 74(17 Supplement 3):S67-S74.
Score: 0.112
-
Overall Graft Loss Versus Death-Censored Graft Loss: Unmasking the Magnitude of Racial Disparities in Outcomes Among US Kidney Transplant Recipients. Transplantation. 2017 Feb; 101(2):402-410.
Score: 0.108
-
The Impact of Health Care Appointment Non-Adherence on Graft Outcomes in Kidney Transplantation. Am J Nephrol. 2017; 45(1):91-98.
Score: 0.106
-
Incidence and risk factors of hepatocellular carcinoma after orthotopic liver transplantation. Surgery. 2017 03; 161(3):830-836.
Score: 0.105
-
Impact of Cardiovascular Risk Factors on Graft Outcome Disparities in Black Kidney Transplant Recipients. Hypertension. 2016 09; 68(3):715-25.
Score: 0.103
-
Quantifying the Race Stratified Impact of Socioeconomics on Graft Outcomes in Kidney Transplant Recipients. Transplantation. 2016 07; 100(7):1550-7.
Score: 0.103
-
Depression, Resource Utilization, and Outcomes Following Liver Transplant. Prog Transplant. 2016 Sep; 26(3):270-6.
Score: 0.103
-
Racial disparity outcomes in patients undergoing hepatectomy: is baseline kidney function a potential explanation? Prog Transplant. 2015 Sep; 25(3):257-62.
Score: 0.097
-
African-American race modifies the influence of tacrolimus concentrations on acute rejection and toxicity in kidney transplant recipients. Pharmacotherapy. 2015 Jun; 35(6):569-77.
Score: 0.096
-
Significant racial differences in the key factors associated with early graft loss in kidney transplant recipients. Am J Nephrol. 2014; 40(1):19-28.
Score: 0.090
-
Are thiazide diuretics safe and effective antihypertensive therapy in kidney transplant recipients? Am J Nephrol. 2013; 38(4):285-91.
Score: 0.085
-
Incidence and patterns of persistent opioid use in children following appendectomy. J Pediatr Surg. 2022 Dec; 57(12):912-919.
Score: 0.039
-
The Magnitude and Potential Causes of Sex Disparities in Statin Therapy in Veterans with Type 2 Diabetes: A 10-year Nationwide Longitudinal Cohort Study. Womens Health Issues. 2022 May-Jun; 32(3):274-283.
Score: 0.038
-
Unfractionated and Low-Molecular-Weight Heparin for Bridging Patients with Left Ventricular Assist Device: An Event-Based Analysis. ASAIO J. 2021 12 01; 67(12):1277-1283.
Score: 0.038
-
The impact of race on metabolic, graft, and patient outcomes after pancreas transplantation. Am J Surg. 2022 04; 223(4):812-816.
Score: 0.036
-
An Evaluation of Statin Use Among Patients with Type 2 Diabetes at High Risk of Cardiovascular Events Across Multiple Health Care Systems. J Manag Care Spec Pharm. 2020 Sep; 26(9):1090-1098.
Score: 0.034
-
Impact of Race and Location of Residence on Statin Treatment Among Veterans With Type 2 Diabetes Mellitus. Am J Cardiol. 2020 05 15; 125(10):1492-1499.
Score: 0.033
-
Assessment of magnetic resonance imaging derived fat fraction as a sensitive and reliable predictor of myosteatosis in liver transplant recipients. HPB (Oxford). 2020 01; 22(1):102-108.
Score: 0.032
-
Creating a 13-year National Longitudinal Cohort of veterans with chronic kidney disease. BMC Nephrol. 2019 07 03; 20(1):241.
Score: 0.032
-
Utility of the Surgical Apgar Score in Kidney Transplantation: Is it Feasible to Predict ICU Admission, Hospital Readmission, Length of Stay, and Cost in This Patient Population? Prog Transplant. 2016 Jun; 26(2):122-8.
Score: 0.025
-
Does African American Race Impact Statin Efficacy in Renal Transplant Outcomes? Medicine (Baltimore). 2015 Dec; 94(49):e2283.
Score: 0.025
-
Incidence, risk factors, and outcomes of opportunistic infections in pediatric renal transplant recipients. Pediatr Transplant. 2016 Feb; 20(1):44-8.
Score: 0.025
-
Optimizing finite resources: Pharmacist chart reviews in an outpatient kidney transplant clinic. J Am Pharm Assoc (2003). 2015 Nov-Dec; 55(6):613-620.
Score: 0.025
-
Is cirrhosis a contraindication to laparoscopic cholecystectomy? Am Surg. 2015 Jan; 81(1):52-5.
Score: 0.023
-
The impact of diabetes mellitus and glycemic control on clinical outcomes following liver transplant for hepatitis C. Clin Transplant. 2014 Aug; 28(8):862-8.
Score: 0.022